Characterization of a stable, metronidazole-resistant Clostridium difficile clinical isolate.

Lynch, Tarah; Chong, Patrick; Zhang, Jason; Hizon, Romeo; Du, Tim; Graham, Morag R; Beniac, Daniel R; Booth, Timothy F; Kibsey, Pamela; Miller, Mark; Gravel, Denise; Mulvey, Michael R

Lynch, Tarah; Chong, Patrick; Zhang, Jason; Hizon, Romeo; Du, Tim; Graham, Morag R; Beniac, Daniel R; Booth, Timothy F; Kibsey, Pamela; Miller, Mark; Gravel, Denise; Mulvey, Michael R.

Affiliation

Lynch T; National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.

PLoS One ; 8(1): e53757, 2013.

Article in En | MEDLINE | ID: mdl-23349739

Subject(s)

Anti-Bacterial Agents/pharmacology; Clostridioides difficile/drug effects; Clostridioides difficile/isolation & purification; Drug Resistance, Bacterial/drug effects; Metronidazole/pharmacology; Clostridioides difficile/genetics; Clostridioides difficile/ultrastructure; Drug Resistance, Bacterial/genetics; Drug Resistance, Multiple/drug effects; Genomics; Humans; Phenotype; Polymorphism, Single Nucleotide

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Health context: 3_ND Database: MEDLINE Main subject: Clostridioides difficile / Drug Resistance, Bacterial / Metronidazole / Anti-Bacterial Agents Type of study: Prognostic_studies Limits: Humans Language: En Journal: PLoS One Year: 2013 Document type: Article

Fulltext

XML

PubMed Links

Search on Google